Marijuana Stock Movers For March 13, 2024
Portfolio Pulse from Benzinga Insights
Marijuana stocks experienced significant movements on March 13, 2024, with notable gainers including Global Hemp Group, Blueberries Medical, and 4Front Ventures, among others. Conversely, MedMen Enterprises led the losers, experiencing a dramatic 90% decline. Other companies such as AusCann Group Holdings and Elixinol Wellness also saw substantial drops. The movements reflect the volatile nature of the marijuana stock market.
March 13, 2024 | 9:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Corbus Pharmaceuticals shares increased by 4.91% to $46.77, reflecting a positive investor outlook.
The rise in Corbus Pharmaceuticals' stock price indicates a bullish sentiment among investors, possibly driven by optimistic company updates or broader sector trends.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Eastside Distilling shares went up by 3.86% to $1.21, showing investor confidence.
The increase in Eastside Distilling's stock price could be attributed to positive market reception or favorable company developments, indicating investor confidence.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Genetic Technologies shares rose by 3.31% to $2.65, suggesting a positive market reaction.
The uplift in Genetic Technologies' stock price reflects a positive investor response, likely due to encouraging company news or sector-wide trends.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
22nd Century Group shares closed up 9.30% at $0.14, indicating a positive market response.
The increase in 22nd Century Group's stock price suggests a positive investor sentiment towards the company, potentially due to favorable market conditions or company-specific news.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
MedMen Enterprises shares plummeted by 90% to $0.00, indicating severe investor concerns.
The dramatic decline in MedMen Enterprises' stock price suggests significant investor worries, possibly due to adverse company news or regulatory challenges.
CONFIDENCE 90
IMPORTANCE 100
RELEVANCE 100